Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Acasti Pharma (ACST)

0.207   0.007 (3.24%) 10-24 21:46
Open: 0.2005 Pre. Close: 0.2005
High: 0.207 Low: 0.2001
Volume: 1,391,955 Market Cap: 19M
Acasti Pharma, Inc. engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. The company is headquartered in Laval, Quebec and currently employs 15 full-time employees. The firm is focused on the research, development and commercialization of prescription drugs using omega 3 fatty acids (OM3s) derived from krill oil. OM3s has clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia (HTG). The firm's drug candidate is CaPre, an OM3 phospholipid, which is being developed for the treatment of severe hypertriglyceridemia, a condition characterized by abnormally high levels of triglycerides in the bloodstream (over 500 mg/dL) (severe hypertriglyceridemia or severe HTG).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.21 - 0.211 0.211 - 0.212
Low: 0.198 - 0.199 0.199 - 0.2
Close: 0.208 - 0.21 0.21 - 0.212

Technical analysis

as of: 2020-10-23 4:40:12 PM
Stoxline posted a STRONG BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 0.31     One year: 0.35
Support: Support1: 0.20    Support2: 0.17
Resistance: Resistance1: 0.26    Resistance2: 0.30
Pivot: 0.21
Moving Average: MA(5): 0.20     MA(20): 0.21
MA(100): 0.52     MA(250): 0.86
MACD: MACD(12,26): -0.03     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 7.22     %D(3): 2.41
RSI: RSI(14): 39.18
52-week: High: 3.08  Low: 0.18  Change(%): -89.0
Average Vol(K): 3-Month: 639824  10-Days: 200493

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
ACST has closed below upper band by 47.4%. Bollinger Bands are 90.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ACST's normal range. The bands have been in this narrow range for 24 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 22 Oct 2020
Acasti Pharma Inc. (ACST) : A Sitting Duck With More Than 1035% Upside - Stocks Register

Wed, 14 Oct 2020
Are Investors Coy about Acasti Pharma Inc. (NASDAQ:ACST)? - Stocks Register

Wed, 14 Oct 2020
Acasti Pharma Inc. (NASDAQ:ACST) Recent Earnings Shows Major Promise - The Oracle Dispatch

Tue, 13 Oct 2020
Why should you add Acasti Pharma Inc. (ACST) to your portfolio? - Marketing Sentinel

Wed, 07 Oct 2020
You Need to See this stock? Acasti Pharma Inc. (ACST) - Digital Market News

Tue, 06 Oct 2020
Is this stock is Attractive? Acasti Pharma (ACST) - Digital Market News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 97
Shares Float (M) 94
% Held by Insiders 9.29
% Held by Institutions 6.09
Shares Short (K) 1,090
Shares Short P. Month (K) 240

Stock Financials

EPS -0.244
EPS Est This Year -0.730
EPS Est Next Year -0.770
Book Value (p.s.) 0.120
Profit Margin
Operating Margin
Return on Assets (ttm) -53.8
Return on Equity (ttm) -310.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.197
Qtrly Earnings Growth
Operating Cash Flow (M) -20
Levered Free Cash Flow (M) -15

Stock Valuations

PE Ratio -0.85
PEG Ratio
Price to Book value 1.72
Price to Sales
Price to Cash Flow -0.98

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.